# Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury

> **NCT02207101** · NA · COMPLETED · sponsor: **Vedic Lifesciences Pvt. Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Cardiac Function in Young Athletes

## Interventions

- **DIETARY_SUPPLEMENT:** E-OJ-01 (OXYJUN)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02207101
- **Lead sponsor:** Vedic Lifesciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207101, "Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02207101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*